SCHEMBL9683473

SCHEMBL9683473

Fc1cc(Br)ccc1CN1CC(Cl)=CC=C1S

nearest known ligand 0.41

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
TRAP1 Q12931 5/20 0.41
HSP90B1 P14625 3/20 0.41
CHRM5 P08912 1/20 0.40
GRM2 Q14416 1/20 0.39
HSP90AA1 P07900 2/20 0.39
HSP90AB1 P08238 1/20 0.38
AKR1A1 P14550 1/20 0.37
AKR1B1 P15121 1/20 0.37
OPRM1 P35372 3/20 0.36
MAOB P27338 1/20 0.35
P2RX7 Q99572 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1951084 0.67 GRM2 (0.46) TRAP1HSP90B1CHRM5GRM2AKR1B1
SCHEMBL1641009 0.65 KDM4E (0.67) OPRM1
SCHEMBL1424192 0.65 BDKRB1 (0.50) TRAP1HSP90B1CHRM5GRM2AKR1B1
SCHEMBL1427498 0.64 KDM4E (0.70) OPRM1
SCHEMBL28954747 0.63 HDAC1 (0.47) GRM2AKR1B1OPRM1P2RX7
SCHEMBL14892161 0.63 PYCR1 (0.46) TRAP1HSP90B1CHRM5AKR1B1
SCHEMBL2095254 0.63 PYCR1 (0.46) TRAP1HSP90B1CHRM5HSP90AA1HSP90AB1
SCHEMBL7701 0.63 PYCR1 (0.46) TRAP1HSP90B1CHRM5HSP90AA1HSP90AB1
SCHEMBL30789000 0.63 PYCR1 (0.46) TRAP1HSP90B1CHRM5HSP90AA1HSP90AB1
SCHEMBL24215709 0.63 KDM4E (0.42) TRAP1HSP90B1CHRM5OPRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5128359-A Benzimidazole and azabenzimidazole derivatives which are thromboxane receptor antagonists, their methods of preparation LABORATOIRES UPSA (FR) 1992-07-07 US disclosed
US-5021443-A Noval benzimidazole and azabenzimiazole derivatives which are thromboxane receptor antagonists, their methods of preparation and pharmaceutical compositions in which they are present LABORATOIRES UPSA (FR) 1991-06-04 US disclosed